Category: INO.com Contributors

Stocks Are Down, Talk Of A Recession Coming! It's Time To Panic! Or Is It?

Posted on by Matt Thalman

Matt Thalman - INO.com Contributor - ETFs


A large number of investors, talking media heads, and Wall Street analysts are predicting that the US toward another recession. Even the mention of the 'R' word (recession) sends fear through not only investors blood, but nearly all American's.

Why? Because soon after hearing the word most people begin remembering 2007-08 financial crises which sent the US economy into a 19-month recession, which to make matters worse from a psychological standpoint has been coined 'The Great Recession'. Furthermore, since the 2007-09 recession is still fresh on everyone minds and was terrible in terms of job lose, declining economic activity, low 401-K balances and stock prices, when the 'R' word is used now, everyone immediately thinks of all those terrible things happening again. This causes fear and panic to quickly set in.

From a market standpoint, this can send equity and commodity prices lower, further increasing the likelihood of a recession. (Think self-fulfilling prophecy.)

But let's stop right there for a moment and look at what is really happening with the markets. Continue reading "Stocks Are Down, Talk Of A Recession Coming! It's Time To Panic! Or Is It?" →

McKesson Has Hit A 52-Week Low - Buying Opportunity

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

As the political cycle unfolds into 2016, the entire healthcare cohort has posted shape declines, this was particularly true for McKesson (MCK). This shape decline coincided with heated political rhetoric aimed at the collective cohort of healthcare and more specifically biotech related companies. The cynical sentiment by political frontrunners was largely rooted in the pricing of drugs and cost effective medical access. As candidate threats via legislative action geared towards reining in the costs of drugs unfolded, these actions negatively reverberated through healthcare and biotech stocks alike. The political posturing surrounding potential plans to reign in drug costs are now largely priced into many stocks within the healthcare umbrella. I contend that after the recent sell-off, many healthcare stocks look attractive at these levels, specifically McKesson. Once the political cycle is complete in 2016, these stocks will likely benefit from the mere absence of political headwinds. McKesson has now hit a 52-week low and boasts a P/E of 16 and a PEG of 1.46. McKesson appears very attractive considering its EPS growth, dividend payout, acquisitive mindset and share buyback program. Continue reading "McKesson Has Hit A 52-Week Low - Buying Opportunity" →

Dollar Takes A Plunge; Where Will It Land?

Posted on by Lior Alkalay

Lior Alkalay - INO.com Contributor - Forex


Undoubtedly, this February will be remembered as painful for the dollar. Investors have long awaited the opportunity to short the greenback after a prolonged period of steep gains. When US growth came out surprisingly weak, FX traders pounced, taking the dollar on a brutal roller coaster ride.

Then we had Janet Yellen’s testimony, which suggested banks should be prepared for negative interest rates. Many considered that a hit below the belt as investors were betting on more rate hikes. So now, they’ve got to get ready for negative interest rates? No one was prepared for that remark, despite Yellen’s suggestion that it was only a remote possibility. Of course, now, the million dollar question is, how low can the dollar go?

Short Term Dollar Outlook

As with all corrections, the first catalyst is always about momentum. The question of whether that will lead to a wider correction is fundamental. But what about the imminent target? That’s driven by technical momentum. So what do the technicals say?

Daily Chart of the U.S. Dollar Index
Chart courtesy of Netdania.com

As seen in the Dollar index chart above there are two key levels in this correction. The first is our resistance level at 100. The Dollar index has been attempting to break this level for a while now, though without success. When the Dollar index failed, it was really only a matter of time before the correction would come. And so as it did. Continue reading "Dollar Takes A Plunge; Where Will It Land?" →

Gold Update: Unstoppable?

Posted on by Aibek Burabayev

Aibek Burabayev - INO.com Contributor - Metals


It's been awhile since I posted my last gold update in October. I haven't written about gold because everything was going by the plan: gold fell right after the post and even hit a new low making bears happy. I expected to wait for the week of the 29th of February as it was my time target in that update. But gold's price overshot the recent high which was the starting point for the last drop towards the new bottom invalidating the experiment.

Below is the chart from my earlier gold post to refresh your memory. I added blue call-outs with some new comments to show where it went wrong.

Chart 1: Updated Experimental Gold Chart

Updated Experimental Gold Chart
Chart courtesy of tradingview.com

I shadowed the part of the chart before the post date (October 22nd) to highlight the progress of the price. Gold quickly plunged down from the post date. It went all the way down with the largest drop in November and hit a new multi-year low at the $1046 level at the end. Continue reading "Gold Update: Unstoppable?" →

In Life And Investing Always Remember 'Cheap Is Expensive'

Posted on by Matt Thalman

Matt Thalman - INO.com Contributor - ETFs


I recently overheard a conversation of two gentlemen discussing a home remodeling project. The younger of the two was explaining how he was preparing to paint a few rooms in his home. His wife was picking out colors and he was soon going to purchase the paint and begin his project. The older of the two men listened intently and besides jokingly saying 'have fun with that project,' gave only one piece of advice, 'buy the more expensive paint.'

This comment seemed to catch the younger man off guard and he responded to the advice with, 'but the more expensive paint is nearly double what the lower priced paint is, is it really worth the extra money?' That question was answered with a simple, 'just trust me, it is in the long run.'

If you have ever painted a room you know exactly what both men in this situation are thinking. The younger guy is confused because it's just paint, I am just trying to add some color to my walls and do I really need to spend the extra money. While the older, wiser, guy is trying to save the other from a headache, time and money due to possibly having to repaint the room again down the road.

I mean seriously, it's just paint, right? Continue reading "In Life And Investing Always Remember 'Cheap Is Expensive'" →